Bearpac Medical, the company behind Passio™ a digital handheld drainage system for patients with Malignant Pleural Effusions (MPE) has collaborated with specialist independent medical technology company APR Medtech and signed an exclusive distribution agreement for the sale of the Passio Pump Drainage System in the UK.
The system, which is intended for intermittent draining of recurring and symptomatic pleural effusions, as well as malignant ascites, comprises a Passio catheter, handheld control unit and disposable collection kit, which includes a redressing kit. This is used to perform fluid drainage and then the disposable collection kit connects the Passio pump to an implanted Passio catheter, which activates the pump to start the fluid evacuation into the collection bag.
Michael Pichel, APR Medtech’s technical director said: “The Passio Pump Drainage System is an innovative, next-generation product and we are delighted to be partnering with Bearpac Medical to bring this technology to the NHS and UK private healthcare sector.”
The deal with APR comes after Bearpac obtained the CE Marking to demonstrate that the Passio Pump Drainage System meets EU safety, health or environmental requirements. The certification enables the company to market the system in European Economic Area (EEA) member countries.
Jay Zimmerman, Bearpac’s Medical president said: “This agreement with APR Medtech presents a significant market opportunity for our Passio Pump Drainage System, now with an expanded CE certification to include both pleural and peritoneal indications."